Hla class I sensitization in islet transplant recipients: Report from the collaborative islet transplant registry

Cell Transplantation

Volumn 21, Issue 5, 2012, Pages 901-908

  Naziruddin, Bashoo ^a   Wease, Steve ^b   Stablein, Donald ^b   Barton, Franca B ^b   Berney, Thierry ^c   Rickels, Michael R ^d   Alejandro, Rodolfo ^e  

^a Baylor Simmons Transplant Institute   (United States)

^b EMMES CORPORATION   (United States)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

HLA class I; HLA sensitization; Islet transplantation; Panel reactive antibodies

Indexed keywords

HLA ANTIGEN CLASS 1; IMMUNOSUPPRESSIVE AGENT; PANEL REACTIVE ANTIBODY;

ADULT; ALLELE; ARTICLE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL;

ADULT; ALLELES; DIABETES MELLITUS, TYPE 1; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; ISOANTIBODIES; MALE; MIDDLE AGED; REGISTRIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84862521903     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X612468     Document Type: Article

References (28)

1. Alejandro, R.; Barton, F. B.; Hering, B. J.; Wease, S. 2008 Update from the collaborative islet transplant registry. Transplantation 86:1783-1788; 2008.
2. Bellin, M. D.; Kandaswamy, R.; Parkey, J.; Zhang, H. J.; Liu, B.; Ihm, S. H.; Ansite, J. D.; Witson, J.; Bansal-Pakala, P.; Balamurugan, A. N.; Papas, K. K.; Sutherland, D. E.; Moran, A.; Hering, B. J. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am. J. Transplant. 8:2463-2470; 2008.
3. Bishay, E. S.; Cook, D. J.; El Fettouh, H.; Starling, R. C.; Young, J. B.; Smedira, N. G.; McCarthy, P. M. The impact of HLA sensitization and donor cause of death in heart transplantation. Transplantation 70:220-222; 2000.
4. Campbell, P. M.; Salam, A.; Ryan, E. A.; Senior, P.; Paty, B. W.; Bigam, D.; McCready, T.; Halpin, A.; Imes, S.; Al Saif, F.; Lakey, J. R.; Shapiro, A. M. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. Am. J. Transplant. 7:1242-1248; 2007.
5. Campbell, P. M.; Senior, P. A.; Salam, A.; Labranche, K.; Bigam, D. L.; Kneteman, N. M.; Imes, S.; Halpin, A.; Ryan, E. A.; Shapiro, A. M. High risk of sensitization after failed islet transplantation. Am. J. Transplant. 7: 2311-2317; 2007.
6. Cantarovich, D.; Vistoli, F.; Bignon, J. D. Anti-human leukocyte antigen antibodies after islet transplantation: What do they really mean? Transplantation 86:204-205; 2008.
7. Cardani, R.; Pileggi, A.; Ricordi, C.; Gomez, C.; Baidal, D. A.; Ponte, G. G.; Mineo, D.; Faradji, R. N.; Froud, T.; Ciancio, G.; Esquenazi, V.; Burke, 3rd, G. W.; Selvaggi, G.; Miller, J.; Kenyon, N. S.; Alejandro, R. Allosensitization of islet allograft recipients. Transplantation 84:1413-1427; 2007.
8. CITR Research Group. 2007 update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR). Cell Transplant. 18:753-767; 2009.
9. Ferrari-Lacraz, S.; Berney, T.; Morel, P.; Marangon, N.; Hadaya, K.; Demuylder-Mischler, S.; Pongratz, G.; Pernin, N.; Villard, J. Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation. Transplantation 86:357-359; 2008.
10. Fiorina, P.; Shapiro, A. M.; Ricordi, C.; Secchi, A. The clinical impact of islet transplantation. Am. J. Transplant. 8:1990-1997; 2008.
11. Fuggle, S. V.; Martin, S. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation 86:384-390; 2008.
12. House, A. A.; Chang, P. C.; Luke, P. P.; Leckie, S. H.; Howson, W. T.; Ball, E. J.; Tan, A. K.; Rehman, F.; Muirhead, N.; Hollomby, D. J.; McAlister, V. C.; Hodsman, A. B.; Jevnikar, A. M. Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: Multivariable analysis of 259 kidney retransplants. Transplantation 84:722-728; 2007.
13. Johansson, H.; Lukinius, A.; Moberg, L.; Lundgren, T.; Berne, C.; Foss, A.; Felldin, M.; Kallen, R.; Salmela, K.; Tibell, A.; Tufveson, G.; Ekdahl, K. N.; Elgue, G.; Korsgren, O.; Nilsson, B. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 54: 1755-1762; 2005.
14. Kerman, R. H.; Orosz, C. G.; Lorber, M. I. Clinical relevance of anti-HLA antibodies pre and post transplant. Am. J. Med. Sci. 313:275-278; 1997.
15. Lobo, P. I.; Spencer, C.; Simmons, W. D.; Hagspiel, K. D.; Angle, J. F.; Deng, S.; Markmann, J.; Naji, A.; Kirk, S. E.; Pruett, T.; Brayman, K. L. Development of anti-human leukocyte antigen class 1 antibodies following allogeneic islet cell transplantation. Transplant. Proc. 37:3438-3440; 2005.
16. Mohanakumar, T.; Narayanan, K.; Desai, N.; Ramachandran, S.; Shenoy, S.; Jendrisak, M.; Susskind, B. M.; Olack, B.; Benshoff, N.; Phelan, D. L.; Brennan, D. C.; Fernandez, L. A.; Odorico, J. S.; Polonsky, K. S. A significant role for histocompatibility in human islet transplantation. Transplantation 82:180-187; 2006.
17. Naji, A.; Barker, C. F.; Silvers, W. K. Relative vulnerability of isolated pancreatic islets, parathyroid, and skin allografts to cellular and humoral immunity. Transplant. Proc. 11:560-562; 1979.
18. Olack, B. J.; Swanson, C. J.; Flavin, K. S.; Phelan, D.; Brennan, D. C.; White, N. H.; Lacy, P. E.; Scharp, D. W.; Poindexter, N.; Mohanakumar, T. Sensitization to HLA antigens in islet recipients with failing transplants. Transplant. Proc. 29:2268-2269; 1997.
19. Rickels, M. R.; Collins, H. W.; Naji, A. Amyloid and transplanted islets. N. Engl. J. Med. 359:2729; 2008.
20. Rickels, M. R.; Kamoun, M.; Kearns, J.; Markmann, J. F.; Naji, A. Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity. J. Clin. Endocrinol. Metab. 92:2410-2414; 2007.
21. Rickels, M. R.; Kearns, J.; Markmann, E.; Palanjian, M.; Markmann, J. F.; Naji, A.; Kamoun, M. HLA sensitization in islet transplantation. Clin. Transpl. 413-420; 2006.
22. Ryan, E. A.; Paty, B. W.; Senior, P. A.; Bigam, D.; Alfadhli, E.; Kneteman, N. M.; Lakey, J. R.; Shapiro, A. M. Fiveyear follow-up after clinical islet transplantation. Diabetes 54:2060-2069; 2005.
23. Scornik, J. C.; Zander, D. S.; Baz, M. A.; Donnelly, W. H.; Staples, E. D. Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry. Transplantation 68:1542-1546; 1999.
24. Shapiro, A. M.; Gallant, H. L.; Hao, E. G.; Lakey, J. R.; McCready, T.; Rajotte, R. V.; Yatscoff, R. W.; Kneteman, N. M. The portal immunosuppressive storm: Relevance to islet transplantation? Ther. Drug Monit. 27:35-37; 2005.
25. Stegall, M. D.; Lafferty, K. J.; Kam, I.; Gill, R. G. Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation 61:1272-1274; 1996.
26. The CITR coordinating center and investigators. The Collaborative Islet Transplant Registry Sixth annual report. https://web.emmes.com/study/isl/reports/CITR6thAnnualDataReport120109.pdf
27. Westermark, G. T.; Westermark, P.; Berne, C.; Korsgren, O.; Nordic network for clinical islet transplantation. Wide-spread amyloid deposition in transplanted human pancreatic islets. N. Engl. J. Med. 359:977-979; 2008.
28. Worcester human islet transplantation group. Autoimmunity after islet-cell allo transplantation. N. Engl. J. Med. 355:1397-1399; 2006.